BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15116318)

  • 1. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma.
    Jarboe EA; Thompson LC; Heinz D; McGregor JA; Shroyer KR
    Hum Pathol; 2004 Apr; 35(4):396-402. PubMed ID: 15116318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
    Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
    Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
    Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
    Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
    Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.
    Reesink-Peters N; Helder MN; Wisman GB; Knol AJ; Koopmans S; Boezen HM; Schuuring E; Hollema H; de Vries EG; de Jong S; van der Zee AG
    J Clin Pathol; 2003 Jan; 56(1):31-5. PubMed ID: 12499429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K
    Diagn Cytopathol; 2006 Nov; 34(11):739-48. PubMed ID: 17041957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined p16INK4a and human papillomavirus testing improves the prediction of cervical intraepithelial neoplasia (CIN II-III) in Thai patients with low-grade cytological abnormalities.
    Ekalaksananan T; Pientong C; Kongyingyoes B; Chaiwongkot A; Yuenyao P; Kleebkaow P; Kritpetcharat O; Evans MF
    Asian Pac J Cancer Prev; 2011; 12(7):1777-83. PubMed ID: 22126564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
    Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
    J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of features indicating progression in atypical squamous cells with undetermined significance: human papillomavirus typing and DNA ploidy analysis from liquid-based cytologic samples.
    Bollmann R; Méhes G; Torka R; Speich N; Schmitt C; Bollmann M
    Cancer; 2003 Apr; 99(2):113-7. PubMed ID: 12704691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.
    Li K; Yin R
    Medicine (Baltimore); 2015 Feb; 94(5):e435. PubMed ID: 25654377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias.
    Tsezou A; Oikonomou P; Kollia P; Mademtzis I; Kostopoulou E; Messinis I; Vamvakopoulos N
    Exp Biol Med (Maywood); 2005 Apr; 230(4):263-70. PubMed ID: 15792948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.